文献速递肿瘤 PET/CT放射性药物与辐射防护

实验室确诊的无症状SARS-CoV-2(COVID-19)感染在18F-FDG PET/CT上的表现

Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2020-01-01

一名87岁原发性唾液腺导管癌伴肝转移男性患者因再分期行18F-FDG PET/CT,显示双肺新发FDG摄取增高的磨玻璃影伴小叶间隔增厚、外周分布为主,影像高度提示COVID-19肺炎;患者当时无症状且无活动性肺炎临床证据,但实时逆转录聚合酶链反应检测COVID-19阳性。

要点

  • 无症状门诊患者在疫情期间行PET/CT时也应评估提示COVID-19的影像学表现。
  • 双肺新发FDG高摄取磨玻璃影伴小叶间隔增厚、外周分布为主高度提示COVID-19肺炎。
  • 影像高度提示COVID-19时应联系转诊医生,即使患者无症状。

核心结论

  • 本病例表明,疫情期间即使是无症状的门诊PET/CT患者,也应评估提示COVID-19的影像学表现。

研究设计与样本

  • 病例报告:一名87岁原发性唾液腺导管癌伴肝转移男性患者因再分期行18F-FDG PET/CT。

主要发现

  • 18F-FDG PET/CT显示双肺新发FDG摄取增高的磨玻璃影伴小叶间隔增厚,外周分布为主,判读为高度提示COVID-19肺炎的模式并联系了转诊医生。
  • 患者当时无症状且无活动性肺炎的临床证据,但实时逆转录聚合酶链反应检测COVID-19阳性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An 87-year-old man with primary salivary duct carcinoma and hepatic metastases was referred for restaging. F-FDG PET/CT demonstrated new FDG-avid ground-glass opacities with intralobular septal thickening in both lungs with a peripheral dominant distribution. This was interpreted as a pattern highly suggestive of COVID-19 pneumonia, and the referring physician was contacted. The patient was currently asymptomatic and without clinical evidence of active pneumonia. However, the patient tested positive for COVID-19 using real-time reverse transcription-polymerase chain reaction. This case demonstrates that even asymptomatic outpatients undergoing PET/CT should be evaluated for radiologic findings suggestive of COVID-19 during this pandemic.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Krebs S, Petkovska I, Ho AL, et al. Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CT. Clin Nucl Med. 2020. PMID: 32433161. doi:10.1097/RLU.0000000000003141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。